BONITA ABRAHAM: Open Payments
NPI 1457957367 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 50 payments from 8 companies in 2025. Trend: 2023 $1,274 · 2024 $1,072 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $498 |
| Novo Nordisk Inc | 15 | $362 |
| ABBVIE INC. | 11 | $291 |
| Lilly USA, LLC | 7 | $207 |
| PFIZER INC. | 6 | $113 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $25 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Ozempic, BREZTRI, UBRELVY, FARXIGA, Rybelsus, AIRSUPRA, QULIPTA, ZEPBOUND.
Industry payments across TX — which companies pay providers there.
